Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Elizabeth Calton"'
Autor:
Mareike Berlak, Elizabeth Tucker, Mathurin Dorel, Annika Winkler, Aleixandria McGearey, Elias Rodriguez-Fos, Barbara Martins da Costa, Karen Barker, Elicia Fyle, Elizabeth Calton, Selma Eising, Kim Ober, Deborah Hughes, Eleni Koutroumanidou, Paul Carter, Reda Stankunaite, Paula Proszek, Neha Jain, Carolina Rosswog, Heathcliff Dorado-Garcia, Jan Jasper Molenaar, Mike Hubank, Giuseppe Barone, John Anderson, Peter Lang, Hedwig Elisabeth Deubzer, Annette Künkele, Matthias Fischer, Angelika Eggert, Charlotte Kloft, Anton George Henssen, Michael Boettcher, Falk Hertwig, Nils Blüthgen, Louis Chesler, Johannes Hubertus Schulte
Publikováno v:
Molecular Cancer, Vol 21, Iss 1, Pp 1-19 (2022)
Abstract Background Development of resistance to targeted therapies has tempered initial optimism that precision oncology would improve poor outcomes for cancer patients. Resistance mechanisms, however, can also confer new resistance-specific vulnera
Externí odkaz:
https://doaj.org/article/141d19867f1b4f5b98e903127aa48cab
Autor:
Gudrun Schleiermacher, Deborah A. Tweddle, Louis Chesler, Sally L. George, Olivier Delattre, Didier Surdez, Angel M. Carcaboso, Fariba Nemati, Didier Decaudin, Isabelle Janoueix-Lerosey, Cécile Pierre-Eugène, Maria Eugénia Marques Da Costa, Birgit Geoerger, Alexandra Saint-Charles, Elnaz Saberi-Ansari, Yasmine Iddir, Jaydutt Bhalshankar, Pierre Gestraud, Elaine Del Nery, Angharad Goodman, Simran Dhariwal, J. Ciaran Hutchinson, Sumana Shrestha, Karen Barker, Barbara Martins Da Costa, Yann Jamin, Evon Poon, Harvey Che, Qiong Gao, Elizabeth Calton, Chiara Gorrini, Angela Bellini, Lindi Chen, Irene Jiménez, Elizabeth R. Tucker
Cell line growth curves and PDX data for idasanutlin combination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ade0a51c8dfce371b3bd0d4b0a103fc
https://doi.org/10.1158/1078-0432.22494934.v1
https://doi.org/10.1158/1078-0432.22494934.v1
Autor:
Gudrun Schleiermacher, Deborah A. Tweddle, Louis Chesler, Sally L. George, Olivier Delattre, Didier Surdez, Angel M. Carcaboso, Fariba Nemati, Didier Decaudin, Isabelle Janoueix-Lerosey, Cécile Pierre-Eugène, Maria Eugénia Marques Da Costa, Birgit Geoerger, Alexandra Saint-Charles, Elnaz Saberi-Ansari, Yasmine Iddir, Jaydutt Bhalshankar, Pierre Gestraud, Elaine Del Nery, Angharad Goodman, Simran Dhariwal, J. Ciaran Hutchinson, Sumana Shrestha, Karen Barker, Barbara Martins Da Costa, Yann Jamin, Evon Poon, Harvey Che, Qiong Gao, Elizabeth Calton, Chiara Gorrini, Angela Bellini, Lindi Chen, Irene Jiménez, Elizabeth R. Tucker
Supplementary methods, supplementary tables, supplementary figure legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::469607ba4ba88232995ac733d8951161
https://doi.org/10.1158/1078-0432.22494931
https://doi.org/10.1158/1078-0432.22494931
Autor:
Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, Barbara Martins Da Costa, Karen Barker, Sumana Shrestha, J. Ciaran Hutchinson, Simran Dhariwal, Angharad Goodman, Elaine Del Nery, Pierre Gestraud, Jaydutt Bhalshankar, Yasmine Iddir, Elnaz Saberi-Ansari, Alexandra Saint-Charles, Birgit Geoerger, Maria Eugénia Marques Da Costa, Cécile Pierre-Eugène, Isabelle Janoueix-Lerosey, Didier Decaudin, Fariba Nemati, Angel M. Carcaboso, Didier Surdez, Olivier Delattre, Sally L. George, Louis Chesler, Deborah A. Tweddle, Gudrun Schleiermacher
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research.
BackgroundALKactivating mutations are identified in approximately 10% of newly diagnosed neuroblastomas andALKamplifications in a further 1-2% of cases. Lorlatinib, a third generation ALK inhibitor, will soon be given alongside induction chemotherapy
Publikováno v:
Paediatrics and Child Health. 31:295-299
Approximately 1400 children in England are diagnosed with cancer each year and in these children an abdominal mass is a common finding, particularly in those under 5 years of age. Here we present an initial diagnostic framework and suggested manageme
Autor:
Gareth J. Veal, Philip Berry, Colin Kwok, Orli Yogev, Laura Danielson, Louis Chesler, Sally L George, Karen Barker, Neil J. Sebire, Barbara Martins da Costa, Till Möcklinghoff, Hannah Webber, James Campbell, Evon Poon, Gilberto S. Almeida, John Anderson, Magdalena Zarowiecki, Laura Mazzoli Smith, Stefano Lise, Elizabeth Calton, Albert Hallsworth, Bliss Buttery, Yann Jamin, Dimitrios Kleftogiannis, Simon P. Robinson
Publikováno v:
Cancer Research. 79:5382-5393
Neuroblastoma is a pediatric cancer that is frequently metastatic and resistant to conventional treatment. In part, a lack of natively metastatic, chemoresistant in vivo models has limited our insight into the development of aggressive disease. The T
Everyone remembers the adage beloved of medical school professors ‘when you hear hooves, think horses not zebras’ (i.e. most presentations have a common cause) and usually it is good advice. Fever is a very common paediatric presentation and usua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::557587fd4328174a0b4e1d2633c2c52a
https://ora.ox.ac.uk/objects/uuid:b9235fc7-f78b-4499-8db6-1eadb28ac2d7
https://ora.ox.ac.uk/objects/uuid:b9235fc7-f78b-4499-8db6-1eadb28ac2d7
Autor:
David A. Johnston, Saul N. Faust, Robert P. Howlin, Philipp J. Thurner, Mark Mavrogordato, Paul Stoodley, D.J. Bull, Elizabeth Calton, Wilmari L. Niehaus, Stuart C. Clarke, Gareth L. Jones
Publikováno v:
Microbiology. 162:1629-1640
Bacterial infections of central venous catheters (CVCs) cause much morbidity and mortality, and are usually diagnosed by concordant culture of blood and catheter tip. However, studies suggest that culture often fails to detect biofilm bacteria. This
Autor:
Shamez N Ladhani, Julia C. Chisholm, Gayle Appleby, Elizabeth Calton, Kirsty Le Doare, Mike Sharland, Cabin Participants
Publikováno v:
Pediatric Blood & Cancer. 61:1239-1245
Background L-Asparaginase is an integral component of standard chemotherapy regimens for the treatment of acute lymphoblastic leukemia (ALL). Clinical hypersensitivity, a common reason for treatment discontinuation, has been reported in 10-30% of pat
Publikováno v:
The Clinical Teacher. 5:222-225